Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,994 public trials 1,520 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

NCT01421004

Conditions
Advanced Solid Tumors, Excluding Breast Cancer, Neoplasms
Locations
  • City of Hope National Medical Center SC-2 Duarte, California, United States
  • University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • Florida Cancer Specialists Sarasota Office Fort Myers, Florida, United States
View all 14 locations
View Trial Details
Completed

Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors

NCT01155713

Conditions
Cancer, Neoplasm, Neoplasms, +1 more
Locations
  • Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service Scottsdale, Arizona, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Sarah Cannon Research Institute Sarah Cannon Research Instit Nashville, Tennessee, United States
  • University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors

NCT01030055

Conditions
Cancer, Neoplasms, Tumors
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Duke University Medical Center Cancer Dept Durham, North Carolina, United States
  • University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

NCT01596647

Conditions
Advanced Solid Tumors, Excluding Breast Cancer, Neoplasms
Locations
  • University of Kansas Cancer Center Medical Center Kansas City, Kansas, United States
  • Henry Ford Hospital Henry Ford Detroit, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Comprehensive Cancer Centers Las Vegas, Nevada, United States
View Trial Details
Completed

A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors

NCT00570284

Conditions
Cancer, Neoplasms
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Norwalk, Connecticut, United States
  • Novartis Investigative Site Rockville, Maryland, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View Trial Details

Related conditions